Evidence map›Paper›PMID 37421549›Full record

ReviewVeterinary research communications2023

Comprehensive review of resveratrol as a feed additive in dairy cows: exploring its potential diverse effects and implications.

M R Rezaei Ahvanooei, M A Norouzian, M Hedayati, M H Ghaffari

Abstract readReview
PubMed Publisher
In one paragraph

Review in Veterinary research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

M R Rezaei AhvanooeiDepartment of Animals and Poultry Science, College of Aburaihan, University of Tehran, Tehran, 3391653755, Iran. m.rezaei.a@ut.ac.ir.ORCID http://orcid.org/0000-0002-2489-0082
M A NorouzianDepartment of Animals and Poultry Science, College of Aburaihan, University of Tehran, Tehran, 3391653755, Iran.
M HedayatiCellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-5816-775X
M H GhaffariInstitute of Animal Science, University of Bonn, 53115, Bonn, Germany. morteza1@uni-bonn.de.ORCID http://orcid.org/0000-0002-5811-3492
University of Tehran · IRResearch Institute for Endocrine Sciences · IRUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heat stress and growing demand for dairy products in tropical regions exert metabolic pressure on dairy cows, leading to metabolic diseases and economic losses. Resveratrol (RSV) is known for its numerous beneficial health effects and can be used as a barrier against metabolic abnormalities and prevent economic losses. Several studies have investigated the effects of RSV in humans and various animal species. In this review, we attempted to investigate the effects of RSV from different aspects so that we could have a practical proposal for its utilization in dairy cows. RSV was found to have potential antioxidant, anti-inflammatory, anti-obesity, and antimicrobial effects, leading to improved reproductive performance. It is interesting that the effect of RSV on the microbial population leads to a significant decrease in methane emissions. However, high doses of RSV have been associated with possible adverse effects, underscoring the dose dependence of its efficacy. In conclusion, RSV polyphenol at optimal doses is a promising agent for the prevention and treatment of metabolic abnormalities in dairy cows, based on our literature review and study results.

Indexed as

LactationMilkAnimal FeedAnimalsCattleDietFemaleHumansResveratrolResveratrolAntimicrobialAntioxidantDairy cowsMethane emissionsReproductionResveratrol

Identifiers

PMID37421549
OpenAlexW4383620658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.